Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Freya Deshmane riding on Reinroe Adare Acrobat claimed the top spot and clinched the gold
- Salah sets Premier League record in Liverpool's draw at Newcastle
- India Open Competition in Shotgun begins in Jaipur, paving way for Nationals' qualification
- Hockey India names Amir Ali-led 20-man team for Junior Asia Cup
- Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award
- World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17
COVID: UK begins rollout of Moderna vaccine Last Updated : 08 Apr 2021 02:25:53 AM IST Moderna Amid the concerns over the potential link between the AstraZeneca jab and rare blood clots, the UK on Wednesday rolled out a third Covid-19 vaccine developed by the US-based Biotechnology company Moderna.
The Moderna vaccine follows the Pfizer-BioNTech and Oxford-AstraZeneca jabs, which are already widely in use, the BBC reported.The government said it has ordered seventeen million doses, which will be the third to be administered in the UK since the rollout began in December last year.The vaccine was approved by the medicines regulator, the Medicines and Healthcare products Regulatory Agency, in January."The UK government has secured vaccines on behalf of the entire nation and the vaccination programme has shown our country working together at its best," said Matt Hancock, Health Secretary.The Health Secretary said approximately three out of every five adults had now been vaccinated with at least one dose across the UK, and urged the public to maintain confidence in the rollout, according to Financial Times.A trial of the Oxford-AstraZeneca Covid-19 vaccine on children in the UK has been paused even as the country's medicines regulator probes a possible link of the vaccine with rare blood clots in adults.The trial, which started in February, is evaluating whether the vaccine generates a strong immune response in those aged between 6 and 17.While the trial has been paused, Professor Andrew Pollard from the University of Oxford ruled out safety concerns with the trial itself, the BBC reported.What the scientists are waiting for is more information, said the report.IANS London For Latest Updates Please-
Join us on
Follow us on
172.31.16.186